![Won-Ki Cho](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Won-Ki Cho
Chairman at CHOA PHARMACEUTICAL CO., LTD.
Net worth: 4 M $ as of 2024-05-30
Won-Ki Cho active positions
Companies | Position | Start | End |
---|---|---|---|
CHOA PHARMACEUTICAL CO., LTD. | Chairman | 1987-12-31 | - |
Medipharm
![]() Medipharm Medical DistributorsDistribution Services Medipharm, founded in 2015, is a cannabis concentrate and derivative product manufacturer based in Seongnam, South Korea. The South Korean company has a good manufacturing practices certified facility with ISO standard-built clean rooms and five primary extraction lines for delivering pure and precision-dosed cannabis products. Medipharm invests in research-driven teams, state-of-the-art technology, and downstream purification methodologies to formulate, develop, process, package, and distribute cannabis extracts and advanced cannabinoid-based products to domestic and international markets. The CEO of the private company is Sung-Hwan Cho. | Chairman | - | - |
Career history of Won-Ki Cho
Training of Won-Ki Cho
Pusan National University | Undergraduate Degree |
Pukyong National University | Doctorate Degree |
Kyungpook National University | Undergraduate Degree |
Statistics
International
South Korea | 6 |
Operational
Chairman | 2 |
Undergraduate Degree | 2 |
Doctorate Degree | 1 |
Sectoral
Consumer Services | 4 |
Health Technology | 2 |
Distribution Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
CHOA PHARMACEUTICAL CO., LTD. | Health Technology |
Private companies | 1 |
---|---|
Medipharm
![]() Medipharm Medical DistributorsDistribution Services Medipharm, founded in 2015, is a cannabis concentrate and derivative product manufacturer based in Seongnam, South Korea. The South Korean company has a good manufacturing practices certified facility with ISO standard-built clean rooms and five primary extraction lines for delivering pure and precision-dosed cannabis products. Medipharm invests in research-driven teams, state-of-the-art technology, and downstream purification methodologies to formulate, develop, process, package, and distribute cannabis extracts and advanced cannabinoid-based products to domestic and international markets. The CEO of the private company is Sung-Hwan Cho. | Distribution Services |
- Stock Market
- Insiders
- Won-Ki Cho
- Experience